Find Jobs
Find Jobs Near You – Available Work in Your Location
Skip to job details
OR
Oak Ridge National Laboratory
Distinguished Staff Scientist (Cancer Biology and Radiopharmaceutical Therapy Development and Advanc
Career Insights for Drug Formulation Scientist
See where this job fits in the broader career landscape. Knowing your career path helps you see what's possible from here.
Scorecard
Based on Tennessee data
Review key factors to help you decide if this role fits your goals. How is this calculated?
What they do
A Drug Formulation Scientist performs scientific research with the aim of discovering new solutions or improving existing ones within the field of pharmaceutical formulation. Plans and conducts laboratory experiments, evaluates the results, develops new experiments, performs routine testing procedures, and summarizes findings in reports.
$128,292 / year median in Tennessee
+12% projected growth
Job Description
Requisition Id 16886
For employment at Oak Ridge National Laboratory (ORNL), a Real ID compliant form of identification will be required.
Additionally, ORNL is subject to Department of Energy (DOE) access restrictions. All employees must also be able to obtain and maintain a federal Personal Identity Verification (PIV) card as mandated by Homeland Security Presidential Directive 12 (HSPD-12) and Department of Energy (DOE) Order 473.1A, which requires a favorable post-employment background investigation. To obtain this credential, new employees must successfully complete and pass a Federal Tier 1 background check investigation. This investigation includes a declaration of illegal drug activities, including use, supply, possession, or manufacture within the last year. This includes marijuana and cannabis derivatives, which are still considered illegal under federal law, regardless of state laws. This position requires access to technology that is subject to export control requirements. Successful candidates must be qualified for such access without an export control license. Visa sponsorship is not available for this role.
Overview:
Join Oak Ridge National Laboratory (ORNL), in collaboration with the University of Tennessee (UT) Oak Ridge Innovation Institute (ORII) Convergent Research Initiative, as we advance radiopharmaceutical therapies. The position will be with the Isotope Applications Research Group (IARG) within the Radioisotope Science and Technology Division. We seek a Distinguished staff scientist with expertise in cancer cell biology and radiobiology to strengthen preclinical therapeutic evaluation, connect tumor biology with radiopharmaceutical development, and support translation of promising approaches toward clinical application.Research:
The research will focus on advancing radiopharmaceutical therapy, with emphasis on tumor biology and preclinical radiobiology.Areas of interest include:
Mechanistic studies of tumor response to radiation and targeted therapeutics, including DNA damage response, cell-cycle regulation, signaling, resistance, and radiosensitization. Development and use of mammalian cancer model systems, including 2D and advanced in vitro approaches, to evaluate therapeutic response in relevant tumor contexts. Evaluation of radiopharmaceutical constructs and targeted delivery platforms that support improved tumor targeting, therapeutic efficacy, and safety. Quantitative cellular and molecular assays to assess uptake, viability, cytotoxicity, DNA damage, proliferation, biomarker expression, and off-target effects. Integration of cancer biology with radiochemistry, isotope science, dosimetry, imaging, data analysis, and clinical collaborations to support translation. IARG is a multidisciplinary team dedicated to advancing the production, exploration of fundamental properties, and practical applications of radioisotopes produced at ORNL. Comprised of experts ranging from nuclear engineers and radiochemists to organic chemists and cell biologists, IARG pushes the boundaries of technology in the production, isolation, and characterization of radionuclides. Their work not only enhances our understanding of these isotopes but also explores their current and potential future applications, which include innovations in nuclear battery development, cutting-edge research in next-generation nuclear reactors, and the advancement of targeted alpha therapy in cancer treatment.Major Duties/Responsibilities:
Interdisciplinary Collaboration:
Collaborate with researchers across ORNL, UT, and external partners in cancer biology, radiochemistry, nuclear medicine, radiobiology, medical physics, and clinical oncology.Innovative Research:
Conduct research in tumor biology, radiobiology, and therapeutic evaluation to improve targeting, efficacy, and understanding of therapeutic response.Translation and Clinical Integration:
Work with university and clinical partners to help move promising radiopharmaceutical and combination therapy concepts from preclinical studies toward clinical applications.Grant Writing and Fundraising:
Seek external funding opportunities and assist in securing research grants, contracts, and philanthropic support to sustain and expand research activities.Publication and Dissemination:
Publish findings in peer-reviewed journals, present at scientific conferences, and engage in outreach activities that enhance the visibility of ORNL, UT, and ORII.Mentorship and Training:
Assist in mentoring graduate students and interns, offering guidance, support, and professional development opportunities to cultivate a skilled research team.Basic Qualifications:
PhD or equivalent degree in cancer biology, cell biology, molecular biology, biochemistry, pharmacology, biomedical engineering, radiobiology, radiation oncology, or a related field, with 10+ years of relevant experience within the field. Expertise in cancer biology and one or more related areas such as radiobiology, molecular oncology, therapeutic response assays, molecular imaging, targeted delivery, or radiopharmaceutical therapy. Strong record of research accomplishments evidenced by publications, presentations, technical contributions, or other impactful work in a relevant field. Excellent communication skills, capable of conveying complex scientific concepts to diverse audiences.Preferred Qualifications:
Experience with advanced cancer model systems and quantitative cellular or molecular assays used to evaluate therapeutic response, mechanism of action, or radiosensitization. Familiarity with radionuclide or radiopharmaceutical therapy research, targeted delivery or nanomedicine approaches, dosimetry-informed studies, combination therapy strategies, or interdisciplinary translational oncology teams. This position is a regular full-time staff appointment. Initial placement will be commensurate with experience, education, and relevant skills. Continued employment is subject to performance and availability of funding.Security, Credentialing, and Eligibility Requirements:
This position requires the ability to obtain and maintain anHSPD-12 PIV
badge.For employment at Oak Ridge National Laboratory (ORNL), a Real ID compliant form of identification will be required.
Additionally, ORNL is subject to Department of Energy (DOE) access restrictions. All employees must also be able to obtain and maintain a federal Personal Identity Verification (PIV) card as mandated by Homeland Security Presidential Directive 12 (HSPD-12) and Department of Energy (DOE) Order 473.1A, which requires a favorable post-employment background investigation. To obtain this credential, new employees must successfully complete and pass a Federal Tier 1 background check investigation. This investigation includes a declaration of illegal drug activities, including use, supply, possession, or manufacture within the last year. This includes marijuana and cannabis derivatives, which are still considered illegal under federal law, regardless of state laws. This position requires access to technology that is subject to export control requirements. Successful candidates must be qualified for such access without an export control license. Visa sponsorship is not available for this role.